Hematopoietic Stem Cell TransplantationPeripheral Blood Stem Cell TransplantationTransplantation, HomologousTransplantation, AutologousGraft vs Host DiseaseStem Cell TransplantationTransplantation ConditioningBone Marrow TransplantationHematologic NeoplasmsHematopoietic Stem Cell MobilizationStem CellsTreatment OutcomeTissue DonorsGranulocyte Colony-Stimulating FactorHematopoietic Stem CellsTransplantation ChimeraLeukapheresisBusulfanImmunosuppressive AgentsGraft SurvivalMyeloablative AgonistsAntigens, CD34RecurrenceCombined Modality TherapyMelphalanMultiple MyelomaRemission InductionBlood Component RemovalHistocompatibility TestingVidarabineGraft vs Leukemia EffectCord Blood Stem Cell TransplantationCyclophosphamideCytomegalovirus InfectionsAntineoplastic Combined Chemotherapy ProtocolsRetrospective StudiesHistocompatibilityLeukemiaWhole-Body IrradiationGraft vs Tumor EffectSalvage TherapyLeukemia, Myeloid, AcuteDisease-Free SurvivalSurvival RateLeukemia, Myelogenous, Chronic, BCR-ABL PositiveSurvival AnalysisTime FactorsLymphocyte TransfusionLymphocyte DepletionSiblingsLymphoma, Non-HodgkinMyelodysplastic SyndromesT-LymphocytesBlood DonorsPrecursor Cell Lymphoblastic Leukemia-LymphomaNeoplasm, ResidualAnemia, AplasticAntilymphocyte SerumCytomegalovirusEmbryonic Stem CellsHematologic DiseasesImmunocompromised HostEtoposideInfectionAcute DiseaseOpportunistic InfectionsVirus ActivationBlood CellsCytarabineFollow-Up StudiesHodgkin DiseaseAdult Stem CellsMesenchymal Stem Cell TransplantationHLA AntigensKidney TransplantationFlow CytometryHepatic Veno-Occlusive DiseaseChimerismMinor Histocompatibility AntigensImmunosuppressionHematopoiesisBlood Cell CountTransplantationLeukocyte TransfusionLiver TransplantationTransplantation ImmunologyAntineoplastic Agents, AlkylatingCyclosporinePrognosisFatal OutcomeThiotepaTransplantation, IsogeneicAntineoplastic AgentsRoseolovirus InfectionsBone Marrow CellsCell DifferentiationLymphomaCells, CulturedLeukemia, MyeloidImmunophenotyping